Lozol Articles
Optimal thiazide dose sought in Japan
3 November 2008
Cheap BP drugs could save many type 2 diabetic patients' lives
10 September 2007
Bulgarian pharma market grows 18.5%
4 June 2007
Good start for Merck KGaA generics in Italy
5 December 2001
Chiesi of Italy sets out expansion plans for rest of Europe
29 November 2001
Stroke prevention emerges from heart disease
10 January 2001
Kangyu acquires Zhejiang firm
27 September 1999
Chiesi Aims For Top 20 Place In Italian Market
5 August 1998
Servier Seeks German Acquisition
9 December 1996
Interim Financial Results From The USA
18 November 1996
Faulding Receive US Approval For Indapamide
24 June 1996
UK Industry Code of Practice: latest Report
4 March 1996
Disease ManagementThe Way Forward
15 May 1995
PRYOR REPORT SLAMS INDUSTRY OVER PRICES
7 February 1994
COVERSYL GAINS US APPROVAL
31 January 1994
RHONE-POULENC RORER BID FOR OTC DRUG LINK UP
10 January 1994
RHONE-POULENC: A TRANSFORMATION
16 August 1993
ARCOLA LAUNCHES FIRST GENERIC DRUG
9 August 1993
STRONG FIRST QUARTER FOR R-PR
26 April 1993
FRANCE'S SERVIER COMING OUT OF SHELL?
8 March 1993
RHONE-POULENC RORER NET INCOME UP 13.4%
2 November 1992
Showing 1-22 of 22 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
